Allergic Asthma – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Allergic Asthma – Drugs In Development, 2024 report and make more profitable business decisions.
Allergic asthma is a type of asthma triggered by exposure to allergens, substances that induce an allergic reaction in susceptible individuals. When someone with allergic asthma encounters these triggers, their immune system responds by inflaming and constricting the airways, leading to symptoms of asthma. Common allergens that can trigger asthma include pollen, dust mites, pet dander, mold, cockroach droppings, and certain foods. The symptoms of allergic asthma are similar to those of other types of asthma and may include wheezing, coughing, shortness of breath, chest tightness, and difficulty breathing. Symptoms are often worse at night or early in the morning. Allergic asthma is diagnosed through a combination of medical history, physical examination, lung function tests (spirometry), and allergy testing to identify specific triggers.
The Allergic Asthma drugs in development market research report provide comprehensive information on the therapeutics under development for Allergic Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Allergic Asthma and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Allergic Asthma | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 69 molecules, with 57 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Allergic Asthma therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Allergic Asthma pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Allergic Asthma treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AATec Medical GmbHAbbVie Inc
Actinobac Biomed Inc
Aldeyra Therapeutics Inc
ALK-Abello AS
Aslan Pharmaceuticals Ltd
AtoGen Co Ltd
Atrapos Therapeutics LLC
Bilix Co Ltd
BiosanaPharma BV
Butantan Institute
CalciMedica Inc
Celestial Therapeutics Inc
Celltrion Inc
Changchun GeneScience Pharmaceutical Co Ltd
Chronic Airway Therapeutics Ltd
CSL Ltd
CSPC Baike Biopharmaceutical Co Ltd
Curateq Biologics Pvt Ltd
DMS Imaging SA
EffectorBio Inc
Foresee Pharmaceuticals Co Ltd
GBC-HpVac SA
Glenmark Pharmaceuticals Ltd
Hanyang University
Helmholtz Center Munich German Research Center for Health and Environment GmbH
Holoclara Inc
Hunan Jingfeng Pharmaceutical Co Ltd
IGE Therapeutics Inc
ILiAD Biotechnologies LLC
Inmunotek SL
James Cook University
Kither Biotech Srl
La Jolla Institute for Immunology
MD Healthcare Inc
National Research Council of Canada
Neovacs SA
Oak Hill Bio Inc
Oneness Biotech Co Ltd
Oxcia AB
Paradigm Biopharmaceuticals Ltd
PharmAbcine Inc
Pleros Therapeutics Inc
Prommune Inc
Protheragen Inc
Qu Biologics Inc
RAPT Therapeutics Inc
Revalesio Corp
Shanghai Kexin Biotech Co Ltd
Siolta Therapeutics Inc
St. George's University of London
sterna biologicals Gmbh & Co KG
Suzhou xinkanghe Biomedical Technology Co Ltd
Synermore Biologics Co Ltd
TCF GmbH
The Walter and Eliza Hall Institute of Medical Research
Torii Pharmaceutical Co Ltd
University of Connecticut
University of Innsbruck
University of Lyon
University of Manitoba
Vanworld Pharmaceutical (Rugao) Company Ltd
Verona Pharma Plc
Yuhan Corp
Zonhon Biopharma Institute Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Allergic Asthma reports